Endologix (ELGX) Misses Q3 EPS by 3c

November 1, 2016 4:43 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Endologix (NASDAQ: ELGX) reported Q3 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $52.1 million versus the consensus estimate of $51.83 million.

GUIDANCE:

Endologix sees FY2016 revenue of $198-201 million, versus the consensus of $202 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment